Clinical trial
The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive Patients
NCT02234492 is registered in ClinicalTrials.gov with Ottawa Heart Institute Research Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive Patients
- Lead sponsor
- Ottawa Heart Institute Research Corporation
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2014
- Completion date
- October 31, 2018
- Enrollment
- 35 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular disease (cvd), human immunodeficiency virus (hiv)